Insulin Lispro KwikPen
Active substance: Insulin Lispro
INJECTION, SOLUTION · INSULIN LISPRO 100 [iU]/mL
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- INSULIN LISPRO · 100 [iU]/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 6 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-427b-7836-8d19-04cf7d2c1e85,01a1208c-463d-7b3f-adc6-e355bd8a2472,01a1208c-67b8-70c3-8596-8ad5f3dac872,01a1208d-d613-79f1-98b5-33816c0ef552,01a1208d-ff44-74f6-93e8-f8abbf43333e;count=29 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-8222
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS, SUBCUTANEOUS
Sources
- product · openFDA NDC · 0002-8222 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-8222 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-8222 · Verified 2026-10-09 · open in source